# An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy

> **NCT02497547** · PHASE2 · COMPLETED · sponsor: **PepTonic Medical AB** · enrollment: 227 (actual)

## Conditions studied

- Atrophy

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02497547
- **Lead sponsor:** PepTonic Medical AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2015-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02497547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02497547, "An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02497547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*